Millions of Hepatitis C Funding Dollars |
Misappropriated to HIV/AIDS |
(Staunton, VA) The Hepatitis C Research Oversight Partnership (HEPCOP) has publicly denounced the National Institutes of Health (NIH) for spending millions of dollars budgeted for Hepatitis C (HCV) on research for HIV/AIDS.
Statistics unearthed by HEPCOP clearly show the NIH misrepresenting research funding. HCV grant money was awarded to determine such outcomes as, "Couples-Based HIV/STI Prevention for Injecting Drug Users in Kazakhstan" ($676,058), "Effects of HIV & Host Genetics in China" ($645,840), "HIV-1 infection Among Young Thai Men" and "Nutritional Status In HIV Hispanic Drug Abusers" ($660,216).
HEPCOP contends that a conflict-of-interest exists. The partnership points out that even NIH’s chief HIV/AIDS researcher and the Director of the National Institute of Allergy and Infectious Diseases, which oversees both HIV and HCV research, Anthony Fauci, MD., received a grant totaling $183,959 from the HCV budget for a study that does not benefit patients HCV mono-infected while benefiting those with HIV—an expense that should be funded by the HIV budget.
Read More and please sign on to the request for an ethics investigation. http://www.hcvets.com/NIH/PressRelease/0904.asp